IBM vs LCTX · P/E 25, rev $17.16B vs rev $2.8M
International Business Machines (IBM) versus Lineage Cell Therapeutics Inc (LCTX) — a side-by-side from cached financials, not a winner call.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Latest reported IBM revenue for 2026-06-30 was $17.16B. Net income was $2.17B. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
Latest reported LCTX revenue for 2026-06-30 was $2.8M. Net income was -$3.3M. Revenue was up 62.0% from 2026-03-31 to 2026-06-30. LCTX currently screens at market cap $213.6M.
IBM currently screens at market cap $267.72B and trailing P/E 25.2. LCTX currently screens at market cap $213.6M.
Not investment advice. Open the IBM and LCTX stock pages for the full models.
Not investment advice.